Free-falling demand for COVID-19 tests may still be a headwind on Quest Diagnostics’ overall earnings, but with that removed from the equation, it’s much smoother sailing for the testmaker. For the ...

Feb 1 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab beat fourth-quarter estimates and forecast 2024 sales above Wall Street expectation on Thursday, as it benefits from ...

Quest Diagnostics, Inc. DGX, as part of its two-point strategy, has been focusing on areas with high potential. Yet, the soft industry trends leading to a low volume environment have acted as a ...

July 26 (Reuters) - Laboratory operator Quest Diagnostics Inc (DGX.N), opens new tab beat estimates for quarterly profit on Wednesday, as people returned for regular checkups and tests that were ...

Like other healthcare companies involved with in vitro diagnostics, Quest Diagnostics felt the force of the COVID-19 seesaw in the fourth quarter, as COVID test revenue declined 75%, only partially ...